JP2606 | Editor’s Picks June 2026
Show notes
Join Prof. Rolland Gyulai as he presents his selection of Editor’s Picks from the June 2026 issue:
- First oral TNFR1 inhibitor for mild-to-moderate psoriasis
- Adjuvant treatment with immune checkpoint inhibitors - no benefit in acral melanomas
- Simple biomarkers predict favourable treatment response
- Mogamulizumab-associated rash – new insights into pathogenesis
Read the Editor's Picks here: https://onlinelibrary.wiley.com/doi/10.1111/jdv.70448